University of Colorado - Restoring Efficient Sleep After TBI (CU-REST)

April 19, 2024 updated by: VA Eastern Colorado Health Care System

University of Colorado - Restoring Efficient Sleep After TBI (CU-REST)

Sleep disturbance is a common condition following traumatic brain injury (TBI) and impairs recovery and quality of life. While efficacious interventions exist many are not accessible to all patients due to a variety of factors (e.g., rurality, access to providers). Further, many of the available treatments have not been validated for individuals with moderate/severe TBI. The proposed study will evaluate a guided computerized version of cognitive behavioral therapy for insomnia (cCBT-I) against enhanced treatment as usual (ETU) in individuals with moderate/severe TBI.

Study Overview

Detailed Description

Individuals with a history of moderate to severe TBI experience multi-faceted sleep problems, including greater daytime sleepiness, lesser total sleep time, and difficulties with initiating, maintaining, and self-monitoring sleep. Such sleep complaints may reflect underlying sleep conditions such as insomnia, the prevalence of which is significantly greater among individuals with TBI (29%) compared to members of the general population (10%). As such, treatment of insomnia among individuals with moderate to severe TBI is expected to produce wide-ranging benefits in regards to short- and long-term rehabilitation. Among members of the general population, cognitive behavioral therapy for insomnia (CBT-I) is considered the gold standard for treating insomnia. CBT-I focuses on improving sleep quality via cognitive therapy, behavioral techniques, and psychoeducation. However, access to in-person treatment has been limited by cost, insufficient numbers of adequately trained healthcare providers, and patient perceptions regarding the efficacy of the intervention, as well as additional barriers that may be particularly pertinent for those living with moderate to severe TBI (e.g., limited transportation). Optimally, an intervention for those with TBI and insomnia would show efficacy at reversing sleep inefficiency, and be able to be used with minimal stigma. In addition, the intervention should be highly accessible, low cost, self-sustaining (e.g., portable), and with minimal side effects.

Computerized versions of CBT-I assist in reducing barriers to access and have been found to be acceptable and efficacious in a variety of populations, including those with mild TBI. To date, research among those with moderate to severe TBI has been limited. This study will address this gap by examining the efficacy of a guided computerized CBT-I (CCBT-I) intervention for those with moderate to severe TBI and insomnia. That is, we will implement a free, computerized version of CBT-I, provided in conjunction with guidance (e.g., prompts or reminders to complete modules, help or support using the program and/or completing the modules) by a licensed mental health professional (Study Clinician). As participants will be recruited from the community at-large across the State of Colorado, it is believed that findings will be highly generalizable.

Moreover, both geography (where an individual resides) and challenges with transportation create barriers to treatment access and research participation among those living with moderate to severe TBI. As such, all study procedures will be completed remotely. During the Coronavirus Disease 2019 (COVID-19) pandemic, members of this study team explored and implemented multiple methods to facilitate remote research participation (e.g., video conferencing, data collection via Research Electronic Data Capture [REDCap], mailing study data collection devices). Employing such methods will allow individuals in both rural and urban areas across Colorado to participate.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • History of post-acute (i.e., at least one year after injury) moderate to severe traumatic brain injury
  • Current insomnia
  • Reliable access to the internet
  • Ability to provide informed consent

Exclusion Criteria:

  • Active substance dependence, excluding cannabis
  • Current psychosis
  • Bipolar disorder
  • Current sleep disorders other than insomnia, including sleep apnea
  • Irregular work schedule, shift work, and/or life changes (e.g., newborn) interfering with regular sleep patterns.
  • Currently receiving psychological treatment for insomnia
  • Pregnancy
  • Currently involved in another research interventional trial targeting insomnia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Computerized Cognitive Behavioral Therapy for Insomnia
Self-guided computerized CBT-I program with assistance from a licensed mental health professional.
This is a computerized version of cognitive behavioral therapy for insomnia that is augmented by support from a licensed mental health professional. The intervention consists of 6 modules designed to provide education regarding sleep and insomnia, establish behavioral modifications to reduce insomnia symptoms, and monitor progress. Participants will be able to complete these intervention at their own pace, which will take between 6-9 weeks.
No Intervention: Enhanced Treatment as Usual
ETU is defined as treatment per usual which is enhanced by participating in data collection related to study participation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insomnia Severity Index (ISI)
Time Frame: Change from baseline to post-intervention (CCBT-I arm) or 9 weeks following randomization (ETU arm).
The change in the total score of the ISI, compared across study arms, will be used as the outcome.
Change from baseline to post-intervention (CCBT-I arm) or 9 weeks following randomization (ETU arm).

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total sleep time - discrepancy between sleep diary and actigraphy
Time Frame: Two timepoints: One week prior to the start of the intervention and for the week immediately following completion of the intervention
Change in the discrepancy between sleep diary- and actigraphy-derived total sleep time will be evaluated for the CCBT-I arm.
Two timepoints: One week prior to the start of the intervention and for the week immediately following completion of the intervention
Sleep onset latency - discrepancy between sleep diary and actigraphy
Time Frame: Two collection periods: One week prior to the start of the intervention and for the week immediately following completion of the intervention
Change in the discrepancy between sleep diary- and actigraphy-derived sleep onset latency will be evaluated for the CCBT-I arm.
Two collection periods: One week prior to the start of the intervention and for the week immediately following completion of the intervention
Wake after sleep onset - discrepancy between sleep diary and actigraphy
Time Frame: Two collection periods: One week prior to the start of the intervention and for the week immediately following completion of the intervention
Change in the discrepancy between sleep diary- and actigraphy-derived wake after sleep onset will be evaluated for the CCBT-I arm.
Two collection periods: One week prior to the start of the intervention and for the week immediately following completion of the intervention
Sleep efficiency - discrepancy between sleep diary and actigraphy
Time Frame: Two collection periods: One week prior to the start of the intervention and for the week immediately following completion of the intervention
Change in the discrepancy between sleep diary- and actigraphy-derived sleep efficiency will be evaluated for the CCBT-I arm.
Two collection periods: One week prior to the start of the intervention and for the week immediately following completion of the intervention
Nature and duration of guidance needed to compete intervention
Time Frame: Through study completion, an average of 9 weeks
A full descriptive analysis of participant use of study clinician support will be conducted to assess scalability (CCBT-I arm only). This will be recorded through an electronic log by the study clinician following each contact with a participant. The unit of measure will include items such as the frequency of contact with the study clinician and a qualitative analysis of the nature of the support given.
Through study completion, an average of 9 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lisa A Brenner, PhD, Rocky Mountain VA Mental Illness, Research, and Education Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2022

Primary Completion (Estimated)

June 30, 2024

Study Completion (Estimated)

December 30, 2024

Study Registration Dates

First Submitted

December 14, 2022

First Submitted That Met QC Criteria

January 5, 2023

First Posted (Actual)

January 12, 2023

Study Record Updates

Last Update Posted (Actual)

April 22, 2024

Last Update Submitted That Met QC Criteria

April 19, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insomnia

Clinical Trials on Computerized Cognitive Behavioral Therapy for Insomnia

3
Subscribe